These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6171728)

  • 1. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules].
    Hallwachs O
    MMW Munch Med Wochenschr; 1981 Oct; 123(44):1675-6. PubMed ID: 6171728
    [No Abstract]   [Full Text] [Related]  

  • 2. [Measurement of urinary flow in general practice. Efficacy of beta-sitosterine].
    Klingeberg J
    ZFA (Stuttgart); 1981 Oct; 57(28):1634-7. PubMed ID: 6170181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma].
    Dufour B; Choquenet C; Revol M; Faure G; Jorest R
    Ann Urol (Paris); 1984 May; 18(3):193-5. PubMed ID: 6084978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of prostatic nycturia with standardized extractum radix urticae].
    Stahl HP
    ZFA (Stuttgart); 1984 Jan; 60(3):128-32. PubMed ID: 6201019
    [No Abstract]   [Full Text] [Related]  

  • 7. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study].
    Dörner G; Fritsche C
    ZFA (Stuttgart); 1982 Jan; 58(3):167-9. PubMed ID: 6176081
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
    Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
    Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
    Maver A
    Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. R. Shi, Q. Xie, X. Gang, J. Lun, L. Cheng, A. Pantuck and J. Rao. J Urol 2008; 179: 610-615.
    Ozdemir AT; Serefoglu EC; Balbay MD
    J Urol; 2008 Sep; 180(3):1188; author reply 1188. PubMed ID: 18639898
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with the Peponen capsule in the management of benign prostatic hyperplasia.
    Hamvas A; Corradi G; Hegedüs M; Frang D
    Int Urol Nephrol; 1991; 23(1):51-5. PubMed ID: 1718920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with niflumic acid of pollakiuria in prostatic diseases (457 cases)].
    Aboulker P; Benassayag E
    Ann Urol (Paris); 1970 Sep; 4(3):213-4. PubMed ID: 4097126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 17. Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
    Hald T
    J Urol (Paris); 1995; 101(1):7-9. PubMed ID: 7545735
    [No Abstract]   [Full Text] [Related]  

  • 18. The urodynamic assessment of benign prostatic hyperplasia obstruction.
    Artibani W
    J Urol (Paris); 1995; 101(1):42-4. PubMed ID: 7545728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical diagnosis of benign prostatic hyperplasia].
    Homma Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():327-32. PubMed ID: 12599594
    [No Abstract]   [Full Text] [Related]  

  • 20. Benign prostatic hyperplasia (BPH): when and whom to treat?
    Boccon-Gibod L
    J Urol (Paris); 1995; 101(1):11-2. PubMed ID: 7545717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.